HEBERT, A.; SCHRIEBER, R.; GLAAB, D.; EICHENFIELD, L. Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s77, 2020. DOI: 10.25251/skin.4.supp.77. Disponível em: https://jofskin.org/index.php/skin/article/view/1110. Acesso em: 22 jul. 2024.